Epistaxis clinical trials

Explore recruiting epistaxis clinical trials.

Recruiting epistaxis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Epistaxis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

InsigHHT: A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2 part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-6400 in Adult Healthy Volunteers and Multiple Dose ALN 6400 in Adult Patients with Hereditary Hemorrhagic Telangiectasia (HHT)

France, Spain, Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Phase II randomized study on efficacy of nintedanib for treatment of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients - EPISTOP

France

Therapeutic exploratory (Phase II) EU CTIS Study details

The effect of systemic antibiotics on post-surgical complications and patient-centered outomes in patients undergoing implant surgery with the guided bone regeneration and simultaneous sinus floor elevation.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Intranasal insulin for the prevention of delirium in ICU patients undergoing elective cardiac surgery: a randomized, double blind, placebo controlled pilot trial (INSPIRE)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training of neurosurgical intensive care nurses.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, multiCentre, dOuble-blind, double-duMmy, parallel-group clinical study on efficacy and safety of iBuprofen/N-acetylcysteine fixed dose cOmbination vs. its individual components (ibuprofen and N- acetylcysteine monotherapies) in patients with symptomatic uncomplicated upper respiratory tract infections with wet cough COMBO

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Epistaxis trials by city

Epistaxis in Toronto Epistaxis in Vancouver Epistaxis in Montreal Epistaxis in Calgary Epistaxis in Edmonton Epistaxis in Ottawa Epistaxis in Winnipeg Epistaxis in Quebec City Epistaxis in Hamilton Epistaxis in Kitchener Epistaxis in London Epistaxis in Halifax Epistaxis in New York Epistaxis in Los Angeles Epistaxis in Chicago Epistaxis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease